Company / AR per Share
ALNYLAM PHARMACEUTICALS, INC. AR per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$6.01
FY2025
5-year range
$1.71 / $6.01
FY2021-FY2025
Trend
+86.7%
vs FY2024
Sector context
#15 of 115
Health Care
What the data says
ALNYLAM PHARMACEUTICALS, INC.'s ar per share of $6.01 is higher than 87% of companies in the Health Care sector (FY2025). AR per Share has increased for 7 consecutive years, from $0.19 in FY2018 to $6.01 in FY2025.
Based on SEC 10-K filings.
6.01 in FY2025 with a 5-year CAGR of +45.8%. Top quartile in the Health Care sector.
Improved from $2.65 to $6.01 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +44.8%
- 5-Year CAGR
- +45.8%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 115This company $6.01 Sector average $27.05
▼
-77.8% below sector average
Key checks
Key Insights
- ALNYLAM PHARMACEUTICALS, INC.'s ar per share has grown for 7 consecutive years.
- In FY2025, ar per share increased 86.7% year-over-year.
- Ranks #15 out of 115 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.37 (distress zone, below 1.8 threshold)
- Negative profit margin: -12.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.01 | +86.7% |
| FY2024 | $3.22 | +21.8% |
| FY2023 | $2.65 | +33.6% |
| FY2022 | $1.98 | +16.1% |
| FY2021 | $1.71 | +86.8% |
| FY2020 | $0.91 | +114.7% |
| FY2019 | $0.43 | +125.8% |
| FY2018 | $0.19 | -49.9% |
| FY2017 | $0.38 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026